Higher mean blood pressure (BP) levels were associated with faster rates of visual field progression in patients with glaucoma, according to a retrospective cohort study. Among 985 patients, the ...

China’s National Medical Products Administration (NMPA) has approved the marketing authorisation application of Santen ...

Glaucoma is a silent disease that leads to blindness. However, 90% of blindness cases caused by glaucoma could be prevented ...

Increased intraocular pressure (lOP) is recognised as the principal risk factor for the development of glaucomatous cupping of the optic disc. The hypothesis that it disrupts the function of ...

Glaucoma is a disease that causes optic nerve damage and potential blindness, impacting millions globally. Often asymptomatic, it’s dubbed the 'silent thief of sight.' Regular eye check-ups are ...

Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a pioneering Ripasudil-Timolol combination therapy for ...

While we often prioritise healthcare, eye care sometimes takes a backseat, yet it is crucial for maintaining overall well-ness. Glaucoma is one of the leading causes of blindness, silently affecting ...

Glaucoma comprises a number of diseases that damage the optic nerve, a vital part of the eye responsible for transmitting visual information to the brain. This condition can lead to a decline in ...

Akums launches novel ripasudil+timolol combination for glaucoma and ocular hypertension: Our Bureau, Bengaluru Tuesday, April 1, 2025, 16:40 Hrs [IST] Akums Drugs & Pharmaceutical ...

Drug-loaded contact lenses for glaucoma treatment appear to demonstrate safety and effectiveness in reducing IOP, according to a systematic review published in European Journal of Pharmacology.